share_log

Private Companies in Concord Healthcare Group Co., Ltd. (HKG:2453) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 17% Last Week

Private Companies in Concord Healthcare Group Co., Ltd. (HKG:2453) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 17% Last Week

康和醫療集團股份有限公司的私營公司是最大的投注者,他們的賭注得到了回報,上週股價上漲了17%
Simply Wall St ·  07/12 03:23

Key Insights

主要見解

  • Significant control over Concord Healthcare Group by private companies implies that the general public has more power to influence management and governance-related decisions
  • 59% of the business is held by the top 3 shareholders
  • Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
  • 私人公司對康和醫療集團的重要控制意味着公衆在管理和治理相關決策方面有更大的影響力。
  • 前三大股東持有該企業的59%。
  • 通過公司過去的業績數據和股權研究,人們可以更好地評估一家公司的未來表現。

To get a sense of who is truly in control of Concord Healthcare Group Co., Ltd. (HKG:2453), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are private companies with 44% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

要了解康和醫療集團有誰真正掌控,了解公司的所有權結構就變得非常重要。其中持股最多的是持有44%股權的私人公司群體。換句話說,該群體最有可能從他們對這家公司的投資中獲得最多(或失去最多)的利益。

As a result, private companies were the biggest beneficiaries of last week's 17% gain.

因此,私人公司是上週17%股價漲幅最大的受益者。

In the chart below, we zoom in on the different ownership groups of Concord Healthcare Group.

下面的圖表展示了康和醫療集團的不同持股群體。

big
SEHK:2453 Ownership Breakdown July 12th 2024
SEHK:2453所有權結構2024年7月12日分佈情況

What Does The Lack Of Institutional Ownership Tell Us About Concord Healthcare Group?

康和醫療集團缺乏機構的持股,對我們意味着什麼?

We don't tend to see institutional investors holding stock of companies that are very risky, thinly traded, or very small. Though we do sometimes see large companies without institutions on the register, it's not particularly common.

我們不會看到機構投資者持有非常高風險、交易較少或非常小的公司的股票。雖然有時會看到大公司沒有機構在註冊表上,但這並不是特別普遍的情況。

There are many reasons why a company might not have any institutions on the share registry. It may be hard for institutions to buy large amounts of shares, if liquidity (the amount of shares traded each day) is low. If the company has not needed to raise capital, institutions might lack the opportunity to build a position. On the other hand, it's always possible that professional investors are avoiding a company because they don't think it's the best place for their money. Concord Healthcare Group's earnings and revenue track record (below) may not be compelling to institutional investors -- or they simply might not have looked at the business closely.

公司可能沒有機構在股東名冊中的原因有很多。如果流動性(每日交易的股數)低,機構可能很難買到大量股票。如果公司沒有需要籌集資金,機構可能沒有建立頭寸的機會。或者,專業投資者可能避開某個公司,因爲他們不認爲這是最好的投資去處。康和醫療集團的盈利和營業收入記錄(如下圖所示)可能沒有說服機構投資者,或者他們可能沒有仔細審查這家公司的業務。

big
SEHK:2453 Earnings and Revenue Growth July 12th 2024
SEHK:2453盈利和營業收入增長情況2024年7月12日

Hedge funds don't have many shares in Concord Healthcare Group. Looking at our data, we can see that the largest shareholder is Hongshan Capital Investment Management (Tianjin) Limited with 27% of shares outstanding. For context, the second largest shareholder holds about 17% of the shares outstanding, followed by an ownership of 15% by the third-largest shareholder.

對於康和醫療集團,對沖基金持股不多。從我們的數據來看,最大的股東是持有27%流通股的宏山資本投資管理(天津)有限公司。爲了更好地理解,持有第二大流通股的股東持股約爲17%,第三大股東持股爲15%。

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 59% stake.

股東登記表的更詳細研究告訴我們,前三大股東擁有該公司的59%股權。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

研究公司的機構所有權可以爲您的研究增加價值,但同時調查分析師建議也是很好的做法,以更深入地了解股票的預期表現。我們目前沒有發現任何關於該公司的分析師報道,因此該公司不太可能被廣泛持有。

Insider Ownership Of Concord Healthcare Group

康和醫療集團內部股東的持股情況

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司內部人員的定義可能是主觀的,並在不同的司法管轄區之間有所不同。我們的數據反映了個人內部人員,至少包括董事會成員。管理層最終向董事會負責。然而,經理們成爲執行董事會成員並不罕見,尤其是如果他們是創始人或首席執行官。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。

We can see that insiders own shares in Concord Healthcare Group Co., Ltd.. The insiders have a meaningful stake worth HK$2.8b. Most would see this as a real positive. It is good to see this level of investment by insiders. You can check here to see if those insiders have been buying recently.

我們可以看到內部人士擁有康和醫療集團股票。內部人士持有價值28億港元的有意義的股份。對於內部人士進行投資是好事。您可以在此處查看內部人士最近是否有買入。

General Public Ownership

一般大衆所有權

With a 11% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Concord Healthcare Group. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

佔有11%的股份,一般大衆,主要由個人投資者組成,可以在康和醫療集團中發揮一定的影響力。雖然這種持股比例可能不足以在政策決策方面產生影響,但他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With a stake of 17%, private equity firms could influence the Concord Healthcare Group board. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

持有17%的私人股權投資公司可能會對康和醫療集團的董事會產生影響。有些人可能會喜歡這一點,因爲私募股權投資有時會將管理層視爲和持方的責任主體。但另一方面,私募股權有時會出售持有的股份,即將公司上市。

Private Company Ownership

私有公司的所有權

We can see that Private Companies own 44%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們可以看到私人公司持有已發行股票的44%。這可能值得更深入地研究。如果相關的方,如內部人士,在這些私人公司之一擁有利益,那麼這應該在年度報告中披露。私人公司也可能對該公司有戰略利益。

Public Company Ownership

上市公司所有權

We can see that public companies hold 19% of the Concord Healthcare Group shares on issue. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

我們可以看到公共公司持有康和醫療集團發行的股票的19%。這可能是一個戰略利益,這兩個公司可能有相關的業務利益。他們可能已經進行了分離。這個持股可能值得深入調查。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Concord Healthcare Group you should know about.

儘管考慮擁有一家公司的不同機構是值得的,但還有其他更重要的因素。比如風險。每個公司都有風險,我們已經發現康和醫療集團有一個警告標誌,您應該知道。

If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.

如果您更喜歡覈對具有潛在優越財務狀況的其他公司,則不要錯過此免費的備有強大財務數據支持的有趣公司列表。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容感到擔憂?請直接與我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?對內容感到擔憂?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論